IP Library Patent Application 18672343
Patent Application
App. No. 18/672,343

Process for Preparing an FGFR Inhibitor

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/672,343
Abstract

Disclosed herein are processes for preparing 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one and FGFR inhibitor, as well as polymorphs and/or salt forms thereof.

Claims (45)

1 - 38 . (canceled)

39 . A process of preparing a compound of formula (I):

comprising:

reacting a compound of formula (5):

or a salt thereof with a compound (iii) wherein LG is a leaving group

40 . The process of claim 39 , wherein LG in compound (iii) is a halo.

41 . The process of claim 39 , wherein the resultant compound of formula (I) is crystalline.

42 . The process of claim 39 , wherein the compound of formula (5)

or a salt thereof is prepared by a process comprises removing PG of compound (4)

wherein PG is a protecting group.

43 . The process of claim 42 , wherein the PG is a tert-butoxycarbonyl protecting group.

44 . The process of claim 42 , wherein the compound (4)

is prepared by a process comprising treating a compound of formula (2) or (3):

wherein each PG is an amino protecting group,

with methylamine.

45 . The process of claim 44 , wherein each PG is a tert-butoxycarbonyl protecting group.

46 . The process of claim 44 , wherein compound (2)

is prepared by a process of comprising reacting compound (1)

or a salt thereof, with N-chlorosuccinimide

wherein each PG is an amino protecting group.

47 . The process of claim 46 , wherein each PG is a tert-butoxycarbonyl protecting group.

48 . The process of claim 46 , wherein compound (1)

or salt thereof, is prepared by a process of comprising reacting a compound of formula (e):

wherein R is alkyl, with a compound of formula (f):

and

treating a compound of formula (g)

formed from the reaction of compound (e) and (f), with a compound of formula (h)

or a salt thereof under alkylating reaction conditions to provide a compound of formula (1),

wherein each PG is an amino protecting group and LG in formula (h) is a leaving group.

49 . The process of claim 48 , wherein each PG is a tert-butoxycarbonyl protecting group.

50 . The process of claim 48 , wherein the LG in formula (h) is a mesylate group.

51 . The process of claim 48 , wherein the compound of formula (e):

is prepared by a process comprising reacting 2-(3,5-dimethoxyphenyl)acetic acid with an alcohol and an acid.

52 . The process of claim 51 , wherein R is methyl and the alcohol is methanol.

53 . The process of claim 51 , wherein the acid is sulfuric acid.

54 . A process for preparing a compound of formula (2) and/or formula (3), comprising reacting a compound of formula (1):

or a salt thereof, with a N-chlorosuccinimide to provide a compound of formula (2) and/or (3):

where each PG is an amino protecting group.

55 . The process of claim 54 , wherein the reaction of a compound of formula (1) or a salt thereof with N-chlorosuccinimide provides a compound of formula (2).

56 . The process of claim 54 , wherein each PG is a tert-butoxycarbonyl protecting group.

57 . A process for preparing a compound of formula (4), comprising treating a compound of formula (2) or (3):

with methylamine to give a compound of formula (4)

wherein each PG is an amino protecting group.

58 . The process of claim 57 , wherein the compound of formula (4) is prepared by treating a compound of formula (2) with methylamine.

59 . The process of claim 57 , wherein each PG is a tert-butoxycarbonyl protecting group.

Assignments (2)
ASSIGNEE CHANGE OF ADDRESS Recorded Sep 16, 2025
From: PRINCIPIA BIOPHARMA INC.
To: PRINCIPIA BIOPHARMA INC.
Reel/Frame 072881/0270 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2025
From: ZHU, JIANG; MASJEDIZADEH, MOHAMMAD
To: PRINCIPIA BIOPHARMA, INC.
Reel/Frame 070122/0935 →